TGF-β inhibition reduced the invasive capabilities of glioma cells, increased T cell infiltration into the tumor, and increased CD107a surface expression on CD8+ T cells in the cervical lymph nodes, indicating that TGF-β has broad-ranging effects on both the cancer and immune cells in the SMA-560 murine model [52]. Here, TGFB1 is linked to glioma.